General Information
Revision date
2017-09-29
Product name
Sumatriptan Tablets
Product Synonyms
Sumatriptan Tablets, USP; Sumatriptan Succinate Tablets; Sumatriptan Tablets 25 mg; Sumatriptan Tablets 50 mg; Sumatriptan
1.2.1 Relevant identified uses
Pharmaceutical Use only as directed
Emergency telephone
For Hazardous Materials Incident
Icons in SDS
Company Information
company name
Mylan Inc
e-mail address of the competent person responsible for the Safety Data Sheet
SDScontact@mylan.com
Section 2
SECTION 2: Hazards identification
Pharmaceutical Agent – Handling of this product in its final form presents minimal occupational exposure risk Patients/Consumers: Please refer to the product information insert or product label for appropriate consumer-specific information about this product when used according to the physician’s directions. This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and by Canada’s Food and Drugs Act. It is in solid, final form for direct administration to the patient. Therefore, is it exempt from the US 2012 Hazard Communication Standard, as defined in the 29 CFR 1910.1200(b)(5)(iii) and in Canada’s Hazardous Products Act
2.1 Classification of the substance or mixture
Not classified
2.2 Label elements
Not classified
